Announcement
08 Jun 2020
In June 2020, the Norwegian authorities introduced an export ban on palivizumab, pertuzumab and imatinib due to concerns of domestic shortages following the COVID-19 pandemic. In June, the export ban was terminated.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
08 Jun 2020
Revocation date:
14 Jun 2020
Updated: 08 Jun 2020
Export ban
On 8 June 2020, the Norwegian Medicines Agency introduced an export ban on palivizumab, pertuzumab and imatinib. The export ban on pertuzumab and imatinib was introduced due to concerns of domestic...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.